$RWAY
Runway Growth Finance Corp.

2022 Q4 Form 10-Q Financial Statement

#000095017022021922 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $36.81M $14.50M $17.58M
YoY Change 109.36% -22.1% 4.71%
Cost Of Revenue $15.67M $10.28M $5.326M
YoY Change 194.22% 77.2% 14.01%
Gross Profit $21.13M $17.05M $12.25M
YoY Change 72.48% 33.1% 1.13%
Gross Profit Margin 57.42% 117.61% 69.7%
Selling, General & Admin $2.682M $2.293M $698.9K
YoY Change 283.78% 31.79% -19.77%
% of Gross Profit 12.69% 13.45% 5.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.774M $12.83M $1.325M
YoY Change 109.33% 520.5% 21.89%
Operating Profit $18.36M $4.217M $10.93M
YoY Change 68.01% -60.74% -0.92%
Interest Expense $131.9K $4.382M $8.377M
YoY Change -98.43% -959.18% -13.82%
% of Operating Profit 0.72% 103.91% 76.65%
Other Income/Expense, Net $259.0K
YoY Change 31.11%
Pretax Income $18.49M $11.72M $19.30M
YoY Change -4.21% 14.57% -6.96%
Income Tax
% Of Pretax Income
Net Earnings $18.49M $11.72M $19.30M
YoY Change -4.21% 14.57% -6.96%
Net Earnings / Revenue 50.24% 80.86% 109.81%
Basic Earnings Per Share $0.29
Diluted Earnings Per Share $0.46 $0.29 $486.8K
COMMON SHARES
Basic Shares Outstanding 40.52M 40.76M
Diluted Shares Outstanding 40.77M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.761M $5.774M $4.697M
YoY Change 22.66% 516.56% -68.45%
Cash & Equivalents $5.761M $5.774M $4.697M
Short-Term Investments
Other Short-Term Assets $99.51K $949.8K
YoY Change -47.72% 592.76%
Inventory
Prepaid Expenses $99.51K $949.8K
Receivables
Other Receivables
Total Short-Term Assets $5.761M $7.697M $6.463M
YoY Change -10.86% 216.98% -57.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.126B $910.2M $729.5M
YoY Change 54.39% 40.82% 17.32%
Other Assets
YoY Change
Total Long-Term Assets $1.136B $914.6M $731.9M
YoY Change 55.22% 40.96% 17.19%
TOTAL ASSETS
Total Short-Term Assets $5.761M $7.697M $6.463M
Total Long-Term Assets $1.136B $914.6M $731.9M
Total Assets $1.142B $922.3M $738.3M
YoY Change 54.64% 41.61% 15.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $7.949M $11.80M $7.668M
YoY Change 3.66% 40.87% 19.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $44.77M
YoY Change -100.0% -100.0% -73.2%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.76M $12.06M $52.66M
YoY Change -68.18% -91.8% -69.67%
LONG-TERM LIABILITIES
Long-Term Debt $549.0M $336.5M $79.49M
YoY Change 590.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $549.0M $336.5M $79.49M
YoY Change 590.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.76M $12.06M $52.66M
Total Long-Term Liabilities $549.0M $336.5M $79.49M
Total Liabilities $565.7M $348.6M $132.2M
YoY Change 328.08% 137.06% -23.9%
SHAREHOLDERS EQUITY
Retained Earnings -$19.32M -$23.52M -$267.0K
YoY Change 7136.33%
Common Stock $606.2M $606.5M $606.5M
YoY Change -0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.302M
YoY Change
Treasury Stock Shares
Shareholders Equity $576.1M $573.7M $606.2M
YoY Change
Total Liabilities & Shareholders Equity $1.142B $922.3M $738.3M
YoY Change 54.64% 41.61% 15.39%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income $18.49M $11.72M $19.30M
YoY Change -4.21% 14.57% -6.96%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$195.7M -$91.10M -$66.21M
YoY Change 195.64% 423.54% -37.75%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $101.1M
YoY Change 102.3%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 195.7M 90.06M 69.97M
YoY Change 179.73% 416.28% -41.63%
NET CHANGE
Cash From Operating Activities -195.7M -91.10M -66.21M
Cash From Investing Activities
Cash From Financing Activities 195.7M 90.06M 69.97M
Net Change In Cash -13.38K -1.036M 3.760M
YoY Change -100.36% -2458.78% -72.16%
FREE CASH FLOW
Cash From Operating Activities -$195.7M -$91.10M -$66.21M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
420360
rway Overhead Allocation Expense
OverheadAllocationExpense
655260
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3116563
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
83523
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2946160
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
343843
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
9219
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
651336
rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.088
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-850754
rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0701
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001653384
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022Q3 rway Operating Tax Expense
OperatingTaxExpense
CY2021Q3 rway Operating Tax Expense
OperatingTaxExpense
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity File Number
EntityFileNumber
814-01180
dei Entity Registrant Name
EntityRegistrantName
Runway Growth Finance Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5049745
dei Entity Address Address Line1
EntityAddressAddressLine1
205 N. Michigan Ave.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4200
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60601
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
281‑6270
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40524123
CY2022Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
936593925
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
727323991
CY2022Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
910168945
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
729516274
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5774074
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4696693
CY2022Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4402598
CY2021Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
2368680
CY2022Q3 rway Other Accounts Receivable
OtherAccountsReceivable
1823611
CY2021Q4 rway Other Accounts Receivable
OtherAccountsReceivable
816065
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
99507
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
949768
CY2022Q3 us-gaap Assets
Assets
922268735
CY2021Q4 us-gaap Assets
Assets
738347480
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
170009357
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
59864489
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
336544766
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
79488460
CY2021Q4 rway Reverse Repurchase Agreement
ReverseRepurchaseAgreement
44774963
CY2022Q3 rway Accrued Incentive Fees
AccruedIncentiveFees
7188966
CY2021Q4 rway Accrued Incentive Fees
AccruedIncentiveFees
6010250
CY2022Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
261180
CY2021Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
221243
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3195407
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
249247
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1418045
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1408826
CY2022Q3 us-gaap Liabilities
Liabilities
348608364
CY2021Q4 us-gaap Liabilities
Liabilities
132152989
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
413806
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
413806
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
606063671
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
606047671
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23515173
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266986
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
9301933
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
573660371
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
606194491
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40635858
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41380614
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.12
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.65
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
27328704
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
18610066
us-gaap Investment Income Net
InvestmentIncomeNet
71745693
us-gaap Investment Income Net
InvestmentIncomeNet
53778440
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
3065581
CY2021Q3 us-gaap Management Fee Expense
ManagementFeeExpense
2301656
us-gaap Management Fee Expense
ManagementFeeExpense
8487820
us-gaap Management Fee Expense
ManagementFeeExpense
6647207
CY2022Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
3625686
CY2021Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
2686475
us-gaap Incentive Fee Expense
IncentiveFeeExpense
8590821
us-gaap Incentive Fee Expense
IncentiveFeeExpense
6498482
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3588289
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
812852
us-gaap Interest Expense Debt
InterestExpenseDebt
6070906
us-gaap Interest Expense Debt
InterestExpenseDebt
2302582
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
720115
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
612854
us-gaap Professional Fees
ProfessionalFees
1968036
us-gaap Professional Fees
ProfessionalFees
1433360
CY2022Q3 rway Overhead Allocation Expense
OverheadAllocationExpense
258191
CY2021Q3 rway Overhead Allocation Expense
OverheadAllocationExpense
249141
rway Overhead Allocation Expense
OverheadAllocationExpense
713457
CY2022Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
268806
CY2021Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
23087
us-gaap General Insurance Expense
GeneralInsuranceExpense
806042
us-gaap General Insurance Expense
GeneralInsuranceExpense
69638
CY2022Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
161245
CY2021Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
179500
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
497896
CY2022Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
794124
CY2021Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
738087
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
2226658
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
1447288
CY2022Q3 rway Directors Fees
DirectorsFees
90727
CY2021Q3 rway Directors Fees
DirectorsFees
67750
rway Directors Fees
DirectorsFees
261727
rway Directors Fees
DirectorsFees
201750
rway Operating Tax Expense
OperatingTaxExpense
1073
rway Operating Tax Expense
OperatingTaxExpense
41
CY2022Q3 us-gaap Other Expenses
OtherExpenses
258991
CY2021Q3 us-gaap Other Expenses
OtherExpenses
197540
us-gaap Other Expenses
OtherExpenses
685841
us-gaap Other Expenses
OtherExpenses
539142
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
12831755
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7868942
us-gaap Operating Expenses
OperatingExpenses
30310277
us-gaap Operating Expenses
OperatingExpenses
20215110
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
14496949
CY2021Q3 us-gaap Net Investment Income
NetInvestmentIncome
10741124
us-gaap Net Investment Income
NetInvestmentIncome
41435416
us-gaap Net Investment Income
NetInvestmentIncome
33563330
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
406917
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
718310
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
939377
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4076766
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3182093
CY2021Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1228382
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-28617263
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3172841
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
11721773
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10231052
us-gaap Net Income Loss
NetIncomeLoss
13757530
us-gaap Net Income Loss
NetIncomeLoss
26313723
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2022Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.36
CY2021Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.32
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.01
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.04
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40774154
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40774154
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33160481
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33160481
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41119467
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41119467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32360107
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32360107
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
14496949
CY2021Q3 us-gaap Net Investment Income
NetInvestmentIncome
10741124
us-gaap Net Investment Income
NetInvestmentIncome
41435416
us-gaap Net Investment Income
NetInvestmentIncome
33563330
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
11721773
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10231052
us-gaap Net Income Loss
NetIncomeLoss
13757530
us-gaap Net Income Loss
NetIncomeLoss
26313723
CY2022Q3 us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
13450710
CY2021Q3 us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
11114754
us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
37005717
us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
34597684
CY2022Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
13450710
CY2021Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
11114754
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
37005717
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
34597684
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18976917
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19283828
CY2021Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
8401215
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
26994806
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4022696
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9301933
CY2021Q3 rway Payments For Proceeds From Offering Costs
PaymentsForProceedsFromOfferingCosts
-32542
rway Payments For Proceeds From Offering Costs
PaymentsForProceedsFromOfferingCosts
16000
rway Payments For Proceeds From Offering Costs
PaymentsForProceedsFromOfferingCosts
-37373
CY2022Q3 rway Net Decrease Increase In Net Assets Resulting From Capital Share Transactions
NetDecreaseIncreaseInNetAssetsResultingFromCapitalShareTransactions
-4022696
CY2021Q3 rway Net Decrease Increase In Net Assets Resulting From Capital Share Transactions
NetDecreaseIncreaseInNetAssetsResultingFromCapitalShareTransactions
27345590
rway Net Decrease Increase In Net Assets Resulting From Capital Share Transactions
NetDecreaseIncreaseInNetAssetsResultingFromCapitalShareTransactions
-9285933
rway Net Decrease Increase In Net Assets Resulting From Capital Share Transactions
NetDecreaseIncreaseInNetAssetsResultingFromCapitalShareTransactions
46241261
CY2022Q3 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
-5751633
CY2021Q3 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
26461888
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
-32534120
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
37957300
CY2022Q2 us-gaap Assets Net
AssetsNet
579412004
CY2021Q2 us-gaap Assets Net
AssetsNet
477739097
CY2021Q4 us-gaap Assets Net
AssetsNet
606194491
CY2020Q4 us-gaap Assets Net
AssetsNet
466243685
CY2022Q3 us-gaap Assets Net
AssetsNet
573660371
CY2021Q3 us-gaap Assets Net
AssetsNet
504200985
CY2022Q3 us-gaap Assets Net
AssetsNet
573660371
CY2021Q3 us-gaap Assets Net
AssetsNet
504200985
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1840160
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
331264
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
744756
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40967122
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32690454
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41380614
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31414051
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40635858
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34530614
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40635858
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34530614
us-gaap Profit Loss
ProfitLoss
13757530
us-gaap Profit Loss
ProfitLoss
26313723
us-gaap-supplement Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
392835343
us-gaap-supplement Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
237031073
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
115000509
rway Payment In Kind Interest
PaymentInKindInterest
-6329304
rway Payment In Kind Interest
PaymentInKindInterest
-2427808
us-gaap-supplement Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
150410327
us-gaap-supplement Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
203205733
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
44999747
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
124999118
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
939377
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4076766
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-28617263
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3172841
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4575984
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5539659
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
798764
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
349378
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2033918
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-650685
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1007546
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-197082
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-850261
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
53246
rway Increase Decrease In Accrued Incentive Fees
IncreaseDecreaseInAccruedIncentiveFees
1178716
rway Increase Decrease In Accrued Incentive Fees
IncreaseDecreaseInAccruedIncentiveFees
964069
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
39937
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-164113548
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4955802
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8242458
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
19126
rway Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
439929
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
282000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
100000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
168000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
119000000
rway Proceeds From Reverse Repurchase Agreements
ProceedsFromReverseRepurchaseAgreements
104474375
rway Repayments Of Reverse Repurchase Agreements
RepaymentsOfReverseRepurchaseAgreements
44774963
rway Repayments Of Reverse Repurchase Agreements
RepaymentsOfReverseRepurchaseAgreements
114424914
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9301933
us-gaap Payments Of Dividends
PaymentsOfDividends
37005717
us-gaap Payments Of Dividends
PaymentsOfDividends
7602878
rway Offering Costs From Financing Activities
OfferingCostsFromFinancingActivities
16000
rway Offering Costs From Financing Activities
OfferingCostsFromFinancingActivities
-37373
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18144300
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
165190929
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18905545
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1077381
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13949743
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4696693
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14886246
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5774074
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
936503
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1073
us-gaap Interest Paid Net
InterestPaidNet
3124746
us-gaap Interest Paid Net
InterestPaidNet
1958739
rway Non Cash Portfolio Purchases
NonCashPortfolioPurchases
3380604
rway Non Cash Portfolio Purchases
NonCashPortfolioPurchases
2562120
rway Non Cash Dividend Reinvestments
NonCashDividendReinvestments
26994806
rway Subscriptions Receivable
SubscriptionsReceivable
1139528
CY2022Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.5866
CY2022Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
936593925
CY2022Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
910168945
CY2022Q3 rway Percentage Of Net Assets At Fair Value Restricted To Resale
PercentageOfNetAssetsAtFairValueRestrictedToResale
0.0116
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.2034
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
727323991
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
729516274
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
6647847
CY2021Q4 rway Collateral
Collateral
45000000.0
CY2021Q4 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
44774963
CY2022Q3 rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.044
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40774154
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates.</span></p>
rway Market Value Of Collateral At Least Equal To Repurchase Price In Case Of Reverse Repurchase Agreement Percentage
MarketValueOfCollateralAtLeastEqualToRepurchasePriceInCaseOfReverseRepurchaseAgreementPercentage
1
rway Market Value Of Collateral At Least Equal To Repurchase Price In Case Of Other Reverse Repurchase Agreements Percentage
MarketValueOfCollateralAtLeastEqualToRepurchasePriceInCaseOfOtherReverseRepurchaseAgreementsPercentage
1.02
CY2022Q3 us-gaap Securities For Reverse Repurchase Agreements
SecuritiesForReverseRepurchaseAgreements
0
CY2021Q3 rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.024
rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.045
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33160481
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41119467
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32360107
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
rway Percentage Of Minimum Beneficial Ownership Of Voting Securities For Control
PercentageOfMinimumBeneficialOwnershipOfVotingSecuritiesForControl
0.250
rway Percentage Of Minimum Board Representation For Control
PercentageOfMinimumBoardRepresentationForControl
0.50
rway Percentage Of Maximum Board Representation
PercentageOfMaximumBoardRepresentation
0.50
rway Percentage Of Minimum Net Ordinary Income For Each Calendar For Distribution
PercentageOfMinimumNetOrdinaryIncomeForEachCalendarForDistribution
0.98
rway Percentage Of Minimum Capital Gains Exceed Capital Losses For Distribution For One Year Period
PercentageOfMinimumCapitalGainsExceedCapitalLossesForDistributionForOneYearPeriod
0.982
rway Percentage Of Minimum Distribution Amount Exceeds Distributions For Year
PercentageOfMinimumDistributionAmountExceedsDistributionsForYear
0.04
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q3 us-gaap Dividends Common Stock
DividendsCommonStock
13450710
us-gaap Dividends Common Stock
DividendsCommonStock
37005717
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12783588
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26708902
CY2021Q3 us-gaap Dividends Common Stock
DividendsCommonStock
11114754
us-gaap Dividends Common Stock
DividendsCommonStock
34597684
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2713539
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7602878
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022Q3 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
329284615
CY2022Q3 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
329284615
CY2021Q4 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
186984615
CY2021Q4 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
186984615
rway Cash Flows Related To Unfunded Commitments And Determined Fair Value
CashFlowsRelatedToUnfundedCommitmentsAndDeterminedFairValue
0
CY2021 rway Cash Flows Related To Unfunded Commitments And Determined Fair Value
CashFlowsRelatedToUnfundedCommitmentsAndDeterminedFairValue
0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
744756
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9301933
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
11721773
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10231052
us-gaap Net Income Loss
NetIncomeLoss
13757530
us-gaap Net Income Loss
NetIncomeLoss
26313723
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40774154
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33160481
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41119467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32360107
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
331264
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4022696
CY2022Q3 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
0
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
579412004
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4022696
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
14496949
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
406917
CY2022Q3 rway Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-3182093
CY2022Q3 us-gaap Dividends
Dividends
13450710
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
573660371
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
744756
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9301933
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
606194491
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9301933
rway Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Benefits
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsBenefits
16000
us-gaap Net Investment Income
NetInvestmentIncome
41435416
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
939377
rway Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-28617263
us-gaap Dividends
Dividends
37005717
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
573660371
CY2021Q3 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
575032
CY2021Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
8401215
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
477739097
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18976917
CY2021Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
8401215
CY2021Q3 rway Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Benefits
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsBenefits
-32542
CY2021Q3 us-gaap Net Investment Income
NetInvestmentIncome
10741124
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
718310
CY2021Q3 rway Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-1228382
CY2021Q3 us-gaap Dividends
Dividends
11114754
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
504200985
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1830974
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
26994806
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
466243685
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19283828
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
26994806
rway Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Benefits
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsBenefits
-37373
us-gaap Net Investment Income
NetInvestmentIncome
33563330
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4076766
rway Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-3172841
us-gaap Dividends
Dividends
34597684
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
504200985
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41380614
rway Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
617386489
CY2022Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
910168945
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
729516274
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
657346204
rway Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Amortization Of Fixed Income Premiums Or Accretion Of Discounts
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAmortizationOfFixedIncomePremiumsOrAccretionOfDiscounts
4576734
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
399037328
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
145479437
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
2238726
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-850754
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
-16527076
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
895864273
us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-17714912
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
536309597
rway Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Amortization Of Fixed Income Premiums Or Accretion Of Discounts
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAmortizationOfFixedIncomePremiumsOrAccretionOfDiscounts
5541082
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
235786783
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
202132301
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
15305039
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-418037
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
-6348690
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
553433395
us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-19597914
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-583365
CY2022Q3 rway Derivative Financial Instruments Net Change In Unrealized Investment Of Warrants
DerivativeFinancialInstrumentsNetChangeInUnrealizedInvestmentOfWarrants
-181741
rway Derivative Financial Instruments Net Change In Unrealized Investment Of Warrants
DerivativeFinancialInstrumentsNetChangeInUnrealizedInvestmentOfWarrants
-340837
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
72371
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-418037
CY2021Q3 rway Derivative Financial Instruments Net Change In Unrealized Investment Of Warrants
DerivativeFinancialInstrumentsNetChangeInUnrealizedInvestmentOfWarrants
2463752
rway Derivative Financial Instruments Net Change In Unrealized Investment Of Warrants
DerivativeFinancialInstrumentsNetChangeInUnrealizedInvestmentOfWarrants
3076220
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
595500000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345500000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8955234
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
336544766
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
370000000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
81000000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1511540
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
79488460
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3588289
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
417440
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
376684
CY2022Q3 us-gaap Interest Expense
InterestExpense
4382413
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
6069351
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
798764
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1427894
us-gaap Interest Expense
InterestExpense
8296009
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
811028
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
117343
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
158861
CY2021Q3 us-gaap Interest Expense
InterestExpense
1087232
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2295514
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
349378
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
487277
us-gaap Interest Expense
InterestExpense
3132169
CY2022Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.14
CY2021Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.61
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.65
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.84
CY2022Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.36
CY2021Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.32
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.01
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.04
CY2022Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.01
CY2021Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.02
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.02
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.13
CY2022Q3 rway Investment Company Change In Unrealized Appreciation Depreciation
InvestmentCompanyChangeInUnrealizedAppreciationDepreciation
-0.08
CY2021Q3 rway Investment Company Change In Unrealized Appreciation Depreciation
InvestmentCompanyChangeInUnrealizedAppreciationDepreciation
-0.04
rway Investment Company Change In Unrealized Appreciation Depreciation
InvestmentCompanyChangeInUnrealizedAppreciationDepreciation
-0.70
rway Investment Company Change In Unrealized Appreciation Depreciation
InvestmentCompanyChangeInUnrealizedAppreciationDepreciation
-0.10
CY2022Q3 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.33
CY2021Q3 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.34
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.90
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.07
CY2022Q3 rway Investment Company Accretion Dilution
InvestmentCompanyAccretionDilution
0.02
CY2021Q3 rway Investment Company Accretion Dilution
InvestmentCompanyAccretionDilution
0.03
rway Investment Company Accretion Dilution
InvestmentCompanyAccretionDilution
0.04
rway Investment Company Accretion Dilution
InvestmentCompanyAccretionDilution
0.02
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.12
CY2021Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.60
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.12
CY2021Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.60
CY2022Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0014
CY2021Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0007
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0362
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0162
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40774154
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33160481
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41119467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32360107
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
573660371
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
504200985
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
573660371
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
504200985
CY2022Q3 rway Average Net Assets
AverageNetAssets
577692553
CY2021Q3 rway Average Net Assets
AverageNetAssets
482599112
rway Average Net Assets
AverageNetAssets
594469333
rway Average Net Assets
AverageNetAssets
479314523
CY2022Q3 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0695
CY2021Q3 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0482
us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0633
us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0518
CY2022Q3 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0991
CY2021Q3 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.1006
rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0358
rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0780
CY2022Q3 us-gaap-supplement Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.0664
CY2021Q3 us-gaap-supplement Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.1860
us-gaap-supplement Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.1959
us-gaap-supplement Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.3590
CY2022Q3 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0255
CY2021Q3 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0219
rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0689
CY2022Q3 rway Investment Company Return From Accretion
InvestmentCompanyReturnFromAccretion
0.0014
CY2021Q3 rway Investment Company Return From Accretion
InvestmentCompanyReturnFromAccretion
0.0021
rway Investment Company Return From Accretion
InvestmentCompanyReturnFromAccretion
0.0027
rway Investment Company Return From Accretion
InvestmentCompanyReturnFromAccretion
0.0013
CY2022Q3 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.1182
CY2021Q3 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.1048
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0981
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0982
CY2022Q3 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0632
CY2021Q3 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0426
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0488
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0383
CY2022Q3 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
937408951
CY2021Q4 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
726968588
CY2022Q3 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
8820050
CY2021Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
23598138
CY2022Q3 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
36060057
CY2021Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
21050452
CY2022Q3 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-27240007
CY2021Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
2547686

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-22-021922-index-headers.html Edgar Link pending
0000950170-22-021922-index.html Edgar Link pending
0000950170-22-021922.txt Edgar Link pending
0000950170-22-021922-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rway-20220930.htm Edgar Link pending
rway-20220930.xsd Edgar Link pending
rway-ex31_1.htm Edgar Link pending
rway-ex31_2.htm Edgar Link pending
rway-ex32_1.htm Edgar Link pending
rway-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rway-20220930_cal.xml Edgar Link unprocessable
rway-20220930_def.xml Edgar Link unprocessable
rway-20220930_pre.xml Edgar Link unprocessable
rway-20220930_lab.xml Edgar Link unprocessable
rway-20220930_htm.xml Edgar Link completed